BBIO   $68.54  -2.18% Market Closed After Close 69.5 1.40%

BridgeBio Pharma, Inc.

EMA (20): 2026-02-18 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (50): 2026-02-19 the price crossed down the moving average line and formed a short-term downside trend.

EMA (100): 2026-02-20 the price crossed down the moving average line and formed a short-term downside trend.

RSI: RSI indicator is in the upper part of the neutral territory and it falls. These factors indicate that the downside trend is confirmed. Last signal: entrance to the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: entry into the oversold zone.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.

Trend Type linear up
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -12.71%
EMA (20) date of signal Feb. 18, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -8.75%
EMA (50) date of signal Feb. 19, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -5.30%
EMA (100) date of signal Feb. 20, 2026, 3 a.m.
RSI Signals bearish recovery
RSI (14) Yield -2.93%
RSI (14) date of signal Feb. 27, 2026, 3 a.m.
MACD Signals bearish recovery
MACD Yield -12.71%
MACD date of signal Feb. 18, 2026, 3 a.m.
Stochastic Signals bearish recovery
Stochastic Yield -1.48%
Stochastic date of signal March 2, 2026, 3 a.m.
Updated March 4, 2026, 8:07 p.m.